|
 Welcome to RCRC Independent Review Board
RCRC Independent Review Board has been a trusted and leading provider of professional IRB services for 25 years. RCRC provides IRB review for all phases of research in a variety of therapeutic areas and study designs in the pharmaceutical, biotech and medical device industries, and for single-site, multi-site and mega trials. We also provide ethical review for behavioral and social sciences research including, data collection, repository, surveys, outcomes and registries. We offer multiple meetings weekly with a 24-48 hour turnaround time employing 21 CFR Part 11compliant innovative technologies. RCRC developed SafeSync™ Online Submissions with 256-bit public key encryption and GlobeSync™ Virtual Workspace, a WEB-based document management portal allowing 24/7 secure access to IRB study documents. Fully accredited by the Association for Accreditation of Human Research Protection Programs, Inc. (AAHRPP), we are a group of experienced IRB members and professionals certified as CCRP, CIP, or CQPA. As a partner on your clinical trial, we are committed to providing quality, flexible and responsive service to assist in the successful and timely completion of research studies. Statement of Compliance RCRC Independent Review Board is appropriately constituted, organized, and conducts ethical review in accordance with the U.S. Food and Drug Administration (21 CFR Parts 50 and 56), the Department of Health and Human Services (45 CFR Part 46), the ICH Guidelines for Good Clinical Practice (E6), and the ethical principles outlined in the Belmont Report. RCRC was awarded Full Accreditation by the Association for the Accreditation of Human Research Protection Programs, Inc. (AAHRPP) in March of 2009. RCRC is registered with the United States Department of Health and Human Services (DHHS) IRB Registration System for OHRP and FDA: - Board 1 registration number IRB00006833
- Board 2 registration number IRB00006834
Experience The majority of the board members and special consultants have scientific expertise and experience in a variety of therapeutic areas and study designs in the pharmaceutical, biotech and medical device industries including, but not limited to: - Allergy & Asthma
- Cardiology
- Dermatology
- Endocrinology
- Gastroenterology
- General Internal Medicine
- General Practice
- Hypertension
- Immunology
- Infectious Disease
- Nephrology
- Oncology
- Ophthalmology
- Pharmacy
- Psychiatry
- Rheumatology
- Toxicology
- Urology
The Boards include medical professionals, an attorney and members of the community. Community members do not have scientific or medical backgrounds and serve as lay members. If necessary, each board may utilize a consultant in a specialized area to assist in the review of a protocol requiring expertise beyond, or in addition to, that of the board.
|
